Cargando…

Prognostic Models for Nonmetastatic Triple-Negative Breast Cancer Based on the Pretreatment Serum Tumor Markers with Machine Learning

PURPOSE: Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive disease with poorer prognosis than other subtypes. We aimed to investigate the prognostic efficacy of multiple tumor markers and constructed a prognostic model for stage I-III TNBC patients. Patients and Methods. We incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Huihui, Wu, Shijie, Hu, Jun, Zhang, Kun, Hu, Kaimin, Lu, Yuexin, He, Jiapan, Pan, Tao, Chen, Yiding
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147528/ https://www.ncbi.nlm.nih.gov/pubmed/34054955 http://dx.doi.org/10.1155/2021/6641421

Ejemplares similares

Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients
por: Long, Zhi-Qing, et al.
Publicado: (2019)

Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer
por: Chen, Bo, et al.
Publicado: (2016)

Pretreatment Aspartate Aminotransferase-to-Alanine Aminotransferase (De Ritis) Ratio Predicts the Prognosis of Nonmetastatic Nasopharyngeal Carcinoma
por: Wu, Jiayuan, et al.
Publicado: (2019)

Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area
por: Wei, Zhengbo, et al.
Publicado: (2014)

High expression of UNC5B enhances tumor proliferation, increases metastasis, and worsens prognosis in breast cancer
por: Wu, Shijie, et al.
Publicado: (2020)

Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management
por: Wu, Shijie, et al.
Publicado: (2020)

Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma
por: Shao, Yanxiang, et al.
Publicado: (2019)

Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2
por: Wu, Shijie, et al.
Publicado: (2022)

Hematologic Markers as Prognostic Factors in Nonmetastatic Esophageal Cancer Patients under Concurrent Chemoradiotherapy
por: Wu, Yi-Feng, et al.
Publicado: (2019)

A Bayesian network meta‐analysis of the efficacy of targeted therapies and chemotherapy for treatment of triple‐negative breast cancer
por: Chen, Huihui, et al.
Publicado: (2018)

Preoperative serum lipid profile and outcome in nonmetastatic colorectal cancer
por: Hong, Ting-Ting, et al.
Publicado: (2016)

Association between serum Vitamin D levels and prognostic factors in nonmetastatic breast cancer patients
por: Shahrzad, Mohammad Karim, et al.
Publicado: (2022)

Triple combination therapy for clinically nonmetastatic super‐high‐risk prostate cancer
por: Yoshimura, Koji, et al.
Publicado: (2022)

Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer
por: Cao, Jintao, et al.
Publicado: (2021)

Computed tomography assessment of body composition in patients with nonmetastatic breast cancer: what are the best prognostic markers?
por: Oliveira Júnior, José Carlos, et al.
Publicado: (2022)

Prognostic role of the lymphocyte-to-monocyte ratio in patients undergoing resection for nonmetastatic rectal cancer
por: Wu, Qing-Bin, et al.
Publicado: (2016)

Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population‐based study
por: Xiao, Yu, et al.
Publicado: (2020)

Pretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients
por: Dai, Danian, et al.
Publicado: (2016)

Time‐dependent and nonlinear effects of prognostic factors in nonmetastatic colorectal cancer
por: Chi, Sheng‐Qiang, et al.
Publicado: (2017)

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
por: Misawa, A, et al.
Publicado: (2009)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2015)

Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial
por: Cao, Mengru, et al.
Publicado: (2023)

circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
por: Chen, Bo, et al.
Publicado: (2018)

Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer
por: Chen, Bo, et al.
Publicado: (2016)

Research on Effectiveness of Prior Cancer on Survival Outcomes for Patients with Nonmetastatic Triple-Negative Breast Cancer: A Competing Risk Analysis and Propensity Score Matching Analysis of the SEER Database
por: Chen, Heyan, et al.
Publicado: (2021)

The prognostic value of clinical and pathologic features in nonmetastatic operable male breast cancer
por: Sun, Bo, et al.
Publicado: (2016)

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer
por: Fountzilas, Elena, et al.
Publicado: (2019)

Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma
por: Makino, Tomoyuki, et al.
Publicado: (2023)

Relationship between serum uric acid and metastatic and nonmetastatic rectal cancer patients with undergoing no chemotherapy
por: Yuan, Cheng, et al.
Publicado: (2016)

Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
por: Soady, Kelly J, et al.
Publicado: (2015)

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer
por: Yin, Hsin-Ling, et al.
Publicado: (2016)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2018)

Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy
por: Yang, Fan, et al.
Publicado: (2023)

Identification of Key Prognostic Genes of Triple Negative Breast Cancer by LASSO-Based Machine Learning and Bioinformatics Analysis
por: Chen, De-Lun, et al.
Publicado: (2022)

PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens
por: Chen, Hui, et al.
Publicado: (2023)

Predicting Overall Survival in Patients with Nonmetastatic Gastric Signet Ring Cell Carcinoma: A Machine Learning Approach
por: Li, Xiaomei, et al.
Publicado: (2022)

Prognostic Value of Preoperative Fibrinogen for Predicting Clinical Outcome in Patients with Nonmetastatic Colorectal Cancer
por: Sun, Yu, et al.
Publicado: (2020)

The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer
por: Zhou, Danyang, et al.
Publicado: (2023)

Pretreatment serum markers and lymphocyte response to interleukin-2 therapy
por: Fumagalli, L, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_id366sju77b4mtcogp1to41vjs